{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T05:24:49Z","timestamp":1793856289596,"version":"4.6.1"},"publisher-location":"Cham","reference-count":47,"publisher":"Springer International Publishing","isbn-type":[{"value":"9783031454929","type":"print"},{"value":"9783031454936","type":"electronic"}],"license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024]]},"DOI":"10.1007\/978-3-031-45493-6_14","type":"book-chapter","created":{"date-parts":[[2024,6,14]],"date-time":"2024-06-14T03:03:04Z","timestamp":1718334184000},"page":"267-285","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Endogenous and Exogenous Opioids: Role in Substance Use Disorders"],"prefix":"10.1007","author":[{"given":"Lindsay","family":"Acree","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,6,15]]},"reference":[{"key":"14_CR1","unstructured":"Alkermes, Inc. (2010). Vivitrol (naltrexone for extended-release injectable suspension) package insert. Retrieved December 1, 2017, from https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2010\/021897s015lbl.pdf"},{"key":"14_CR2","doi-asserted-by":"publisher","DOI":"10.1176\/appi.books.9780890425596","volume-title":"Diagnostic and statistical manual of mental disorders","author":"American Psychiatric Association","year":"2013","unstructured":"American Psychiatric Association. (2013). Diagnostic and statistical manual of mental disorders (5th ed.). American Psychiatric Publishing.","edition":"5"},{"key":"14_CR47","doi-asserted-by":"crossref","unstructured":"Berde, C. B., Beyer, J. E., Bournaki, M. C., Levin, C. R., & Sethna, N. F. (1991). Comparison of morphine and methadone for prevention of postoperative pain in 3- to 7-year-old children. The Journal of Pediatrics, 119(1 Pt 1),136\u201341.","DOI":"10.1016\/S0022-3476(05)81054-6"},{"key":"14_CR3","doi-asserted-by":"publisher","first-page":"549272","DOI":"10.3389\/fpsyt.2020.549272","volume":"11","author":"CK Blazes","year":"2020","unstructured":"Blazes, C. K., & Morrow, J. D. (2020). Reconsidering the usefulness of adding naloxone to buprenorphine. Frontiers in Psychiatry, 11, 549272.","journal-title":"Frontiers in Psychiatry"},{"key":"14_CR4","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.brainres.2009.08.062","volume":"1314","author":"MR Bruchas","year":"2010","unstructured":"Bruchas, M. R., Land, B. B., & Chavkin, C. (2010). The dynorphin\/kappa opioid system as a modulator of stress-induced and pro-addictive behaviors. Brain Research, 1314, 44\u201355.","journal-title":"Brain Research"},{"key":"14_CR5","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.drugpo.2017.05.023","volume":"46","author":"JJ Carroll","year":"2017","unstructured":"Carroll, J. J., Marshall, B. D., Rich, J. D., & Green, T. C. (2017). Exposure to fentanyl-contaminated heroin and overdose risk among illicit opioid users in Rhode Island: A mixed methods study. International Journal of Drug Policy, 46, 136\u2013145.","journal-title":"International Journal of Drug Policy"},{"key":"14_CR6","volume-title":"Wide-ranging online data for epidemiologic research (WONDER)","author":"Centers for Disease Control","year":"2016","unstructured":"Centers for Disease Control. (2016). Wide-ranging online data for epidemiologic research (WONDER). CDC, National Center for Health Statistics. Retrieved December 19, 2017, from http:\/\/wonder.cdc.gov"},{"key":"14_CR7","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1016\/j.neuropharm.2013.08.028","volume":"76","author":"P Charbogne","year":"2014","unstructured":"Charbogne, P., Kieffer, B. L., & Befort, K. (2014). 15 years of genetic approaches in vivo for addiction research: Opioid receptor and peptide gene knockout in mouse models of drug abuse. Neuropharmacology, 76, 204\u2013217.","journal-title":"Neuropharmacology"},{"key":"14_CR07","doi-asserted-by":"crossref","unstructured":"Cruz, S. L., & Granados-Soto, V. (2015). Opioids and opiates: pharmacology, abuse, and addiction. Neurosci 21st century. New York: Springer, 3625\u201357.","DOI":"10.1007\/978-1-4939-3474-4_156"},{"key":"14_CR8","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.drugalcdep.2019.01.045","volume":"198","author":"R Daniulaityte","year":"2019","unstructured":"Daniulaityte, R., Juhascik, M. P., Strayer, K. E., Sizemore, I. E., Zatreh, M., Nahhas, R. W., et al. (2019). Trends in fentanyl and fentanyl analogue-related overdose deaths\u2013Montgomery County, Ohio, 2015\u20132017. Drug and Alcohol Dependence, 198, 116\u2013120.","journal-title":"Drug and Alcohol Dependence"},{"issue":"23","key":"14_CR9","doi-asserted-by":"publisher","first-page":"2295","DOI":"10.1001\/jama.2017.15971","volume":"318","author":"D Dowell","year":"2017","unstructured":"Dowell, D., Noonan, R. K., & Houry, D. (2017). Underlying factors in drug overdose deaths. JAMA, 318(23), 2295\u20132296.","journal-title":"JAMA"},{"issue":"12","key":"14_CR10","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1001\/jamapediatrics.2016.2154","volume":"170","author":"JR Gaither","year":"2016","unstructured":"Gaither, J. R., Leventhal, J. M., Ryan, S. A., & Camenga, D. R. (2016). National trends in hospitalizations for opioid poisonings among children and adolescents, 1997 to 2012. JAMA Pediatrics, 170(12), 1195\u20131201.","journal-title":"JAMA Pediatrics"},{"issue":"2","key":"14_CR11","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1016\/j.neubiorev.2010.05.002","volume":"35","author":"O George","year":"2010","unstructured":"George, O., & Koob, G. F. (2010). Individual differences in prefrontal cortex function and the transition from drug use to drug dependence. Neuroscience and Biobehavioral Reviews, 35(2), 232\u2013247.","journal-title":"Neuroscience and Biobehavioral Reviews"},{"key":"14_CR46","doi-asserted-by":"crossref","unstructured":"George, M., Kitzmiller, J. P., Ewald, M. B. et al. (2012). Methadone toxicity and possible induction and enhanced elimination in a premature neonate. Journal of Medical Toxicology, 8, 432\u2013435.","DOI":"10.1007\/s13181-012-0249-8"},{"key":"14_CR12","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1159\/000484909","volume":"25","author":"ZH Gu","year":"2017","unstructured":"Gu, Z. H., Wang, B., Kou, Z. Z., Bai, Y., Chen, T., Dong, Y. L., & Li, Y. Q. (2017). Endomorphins: Promising endogenous opioid peptides for the development of novel analgesics. Neurosignals, 25, 98\u2013116.","journal-title":"Neurosignals"},{"key":"14_CR13","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1002\/ajim.22874","volume":"61","author":"J Howard","year":"2018","unstructured":"Howard, J., & Hornsby-Myers, J. (2018). Fentanyls and the safety of first responders: Science and recommendations. American Journal of Industrial Medicine, 61, 633\u2013639.","journal-title":"American Journal of Industrial Medicine"},{"key":"14_CR14","first-page":"998","volume-title":"Goldfrank\u2019s toxicologic emergencies","author":"MA Howland","year":"1998","unstructured":"Howland, M. A. (1998). Antidotes in depth. In Goldfrank\u2019s toxicologic emergencies (pp. 998\u20131009). Appleton and Lange."},{"key":"14_CR42","unstructured":"Infante, A. F., Elmes, A. T., Gimbar, R. P., Messmer, S. E., Neeb, C., & Jarrett, J. B. (2024). Stronger, longer, better opioid antagonists? Nalmefene is NOT a naloxone replacement. The International Journal on Drug Policy, 4(104323). Retrieved May 7, 2024, from https:\/\/pubmed.ncbi.nlm.nih.gov\/38232438\/#:~:text=The%20U.S.%20Food%20and%20Drug,of%20naloxone%20for%20opioid%20reversal."},{"key":"14_CR15","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1021\/acschemneuro.6b00167","volume":"8","author":"TA Johnson","year":"2017","unstructured":"Johnson, T. A., Milan-Lobo, L., Che, T., Ferwerda, M., Lambu, E., McIntosh, N. L., et al. (2017). Identification of the first marine-derived opioid receptor \u201cbalanced\u201d agonist with a signaling profile that resembles the endorphins. ACS Chemical Neuroscience, 8, 473\u2013485.","journal-title":"ACS Chemical Neuroscience"},{"issue":"4","key":"14_CR17","doi-asserted-by":"publisher","first-page":"e20173335","DOI":"10.1542\/peds.2017-3335","volume":"141","author":"JM Kane","year":"2018","unstructured":"Kane, J. M., Colvin, J. D., Bartlett, A. H., & Hall, M. (2018). Opioid-related critical care resource use in U.S. children\u2019s hospitals. Pediatrics, 141(4), e20173335.","journal-title":"Pediatrics"},{"key":"14_CR18","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1146\/annurev.pharmtox.010909.105826","volume":"50","author":"JY Khokhar","year":"2010","unstructured":"Khokhar, J. Y., Ferguson, C. S., Zhu, A. Z. X., & Tyndale, R. F. (2010). Pharmacogenetics of drug dependence: Role of gene variations in susceptibility and treatment. Annual Review of Pharmacology and Toxicology, 50, 39\u201361.","journal-title":"Annual Review of Pharmacology and Toxicology"},{"key":"14_CR19","first-page":"1","volume":"5","author":"KL Kjome","year":"2011","unstructured":"Kjome, K. L., & Moeller, F. G. (2011). Long-acting injectable naltrexone for the management of patients with opioid dependence. Substance Abuse: Research and Treatment, 5, 1\u20139.","journal-title":"Substance Abuse: Research and Treatment"},{"issue":"9","key":"14_CR20","doi-asserted-by":"publisher","first-page":"200","DOI":"10.24095\/hpcdp.36.9.05","volume":"36","author":"SA Klar","year":"2016","unstructured":"Klar, S. A., Brodkin, E., Gibson, E., Padhi, S., Predy, C., Green, C., & Lee, V. (2016). Furanyl-fentanyl overdose events caused by smoking contaminated crack cocaine\u2014British Columbia, Canada, July 15\u201318, 2016. Health Promotion and Chronic Disease Prevention in Canada: Research, Policy and Practice, 36(9), 200\u2013201.","journal-title":"Health Promotion and Chronic Disease Prevention in Canada: Research, Policy and Practice"},{"issue":"2","key":"14_CR21","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/S0893-133X(00)00195-0","volume":"24","author":"GF Koob","year":"2001","unstructured":"Koob, G. F., & Le Moal, M. (2001). Drug addiction, dysregulation of reward, and allostasis. Neuropsychopharmacology, 24(2), 97\u2013129.","journal-title":"Neuropsychopharmacology"},{"key":"14_CR22","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1146\/annurev-pharmtox-010715-103143","volume":"56","author":"GF Koob","year":"2016","unstructured":"Koob, G. F., & Mason, B. J. (2016). Existing and future drugs for the treatment of the dark side of addiction. The Annual Review of Pharmacology and Toxicology, 56, 299\u2013322.","journal-title":"The Annual Review of Pharmacology and Toxicology"},{"issue":"5","key":"14_CR23","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1177\/070674371305800503","volume":"58","author":"RF Leeman","year":"2013","unstructured":"Leeman, R. F., & Potenza, M. N. (2013). A targeted review of the neurobiology and genetics of behavioral addictions: An emerging area of research. Canadian Journal of Psychiatry, 58(5), 260\u2013273.","journal-title":"Canadian Journal of Psychiatry"},{"issue":"1","key":"14_CR24","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.ajem.2006.07.006","volume":"25","author":"F LoVecchio","year":"2007","unstructured":"LoVecchio, F., Pizon, A., Riley, B., Sami, A., & D\u2019Incognito, C. (2007). Onset of symptoms after methadone overdose. The American Journal of Emergency Medicine, 25(1), 57\u201359.","journal-title":"The American Journal of Emergency Medicine"},{"key":"14_CR25","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1146\/annurev-neuro-070815-013920","volume":"39","author":"C Lucher","year":"2016","unstructured":"Lucher, C. (2016). The emergence of a circuit model for addiction. Annual Review of Neuroscience, 39, 257\u2013276.","journal-title":"Annual Review of Neuroscience"},{"key":"14_CR48","doi-asserted-by":"crossref","unstructured":"Lutfy, K., & Cowan, A. (2004). Buprenorphine: a unique drug with complex pharmacology. Curr Neuropharmacol, 2(4), 395\u2013402.","DOI":"10.2174\/1570159043359477"},{"key":"14_CR26","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1016\/j.conb.2013.02.005","volume":"23","author":"PE Lutz","year":"2013","unstructured":"Lutz, P. E., & Kieffer, B. L. (2013). The multiple facets of opioid receptor function: Implications for addiction. Current Opinion in Neurobiology, 23, 473\u2013479.","journal-title":"Current Opinion in Neurobiology"},{"issue":"4","key":"14_CR27","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1152\/physrev.00005.2009","volume":"89","author":"JL Merrer","year":"2009","unstructured":"Merrer, J. L., Becker, J. A. J., Befort, K., & Keiffer, B. L. (2009). Reward processing by the opioid system in the brain. Physiological Reviews, 89(4), 137\u20131412.","journal-title":"Physiological Reviews"},{"issue":"4","key":"14_CR28","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1080\/15563650.2017.1373782","volume":"56","author":"MJ Moss","year":"2017","unstructured":"Moss, M. J., Warrick, B. J., Nelson, L. S., McKay, C. A., Dube, P., Gosselin, S., Palmer, R. B., Stolbach, A. I., & American Academy of Clinical Toxicology. (2017). ACMT and AACT position statement: Preventing occupational fentanyl and fentanyl analog exposure to emergency responders. Clinical Toxicology, 56(4), 297\u2013300.","journal-title":"Clinical Toxicology"},{"key":"14_CR29","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1146\/annurev-clinpsy-021815-093546","volume":"12","author":"PE Nathan","year":"2016","unstructured":"Nathan, P. E., Conrad, M., & Skinstad, A. H. (2016). History of the concept of addiction. Annual Review of Clinical Psychology, 12, 29\u201351.","journal-title":"Annual Review of Clinical Psychology"},{"issue":"7","key":"14_CR30","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/j.tips.2010.04.003","volume":"31","author":"K Niikura","year":"2010","unstructured":"Niikura, K., Narita, M., Butelman, E. R., Kreek, M. J., & Suzuki, T. (2010). Neuropathic and chronic pain stimuli downregulate central \u03bc-opioid and dopaminergic transmission. Trends in Pharmacological Sciences, 31(7), 299\u2013305.","journal-title":"Trends in Pharmacological Sciences"},{"issue":"5","key":"14_CR31","doi-asserted-by":"publisher","first-page":"577","DOI":"10.2165\/00003495-200969050-00006","volume":"69","author":"JS Orman","year":"2009","unstructured":"Orman, J. S., & Keating, G. M. (2009). Buprenorphine\/naloxone. Drugs, 69(5), 577\u2013607.","journal-title":"Drugs"},{"issue":"10","key":"14_CR32","doi-asserted-by":"publisher","first-page":"1863","DOI":"10.1111\/acer.12810","volume":"39","author":"AR Ozburn","year":"2015","unstructured":"Ozburn, A. R., Janowsky, A. J., & Crabbe, J. C. (2015). Commonalities and distinctions among mechanisms of addiction to alcohol and other drugs. Alcoholism, Clinical and Experimental Research, 39(10), 1863\u20131877.","journal-title":"Alcoholism, Clinical and Experimental Research"},{"issue":"1","key":"14_CR33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12954-018-0240-z","volume":"15","author":"JN Park","year":"2018","unstructured":"Park, J. N., Weir, B. W., Allen, S. T., Chaulk, P., & Sherman, S. G. (2018). Fentanyl-contaminated drugs and non-fatal overdose among people who inject drugs in Baltimore, MD. Harm Reduction Journal, 15(1), 1\u20138.","journal-title":"Harm Reduction Journal"},{"issue":"1","key":"14_CR34","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1177\/2049463712438493","volume":"6","author":"H Pathan","year":"2012","unstructured":"Pathan, H., & Williams, J. (2012). Basic opioid pharmacology: An update. British Journal of Pain, 6(1), 11\u201316.","journal-title":"British Journal of Pain"},{"key":"14_CR35","volume-title":"Opium wars","author":"K Pletcher","year":"2018","unstructured":"Pletcher, K., & Encyclopedia Brittanica, Inc. (2018). Opium wars. Encyclopedia Brittanica. Retrieved January 4, 2019, from: https:\/\/www.britannica.com\/topic\/Opium-Wars"},{"key":"14_CR44","doi-asserted-by":"crossref","unstructured":"Przewlocki, R. & Almeida, O. (2017). 1.08 - Stress and Opioid Systems, Editor(s): Donald W. Pfaff, Marian Jo\u00ebls, Hormones, Brain and Behavior (Third Edition), Academic Press, 2017, Pages 225\u2013260.","DOI":"10.1016\/B978-0-12-803592-4.00008-0"},{"key":"14_CR37","volume-title":"Basic & clinical pharmacology","author":"MA Schumacher","year":"2015","unstructured":"Schumacher, M. A., Basbaum, A. I., & Naidu, R. K. (2015). Opioid agonists & antagonists. In B. G. Katzung & A. J. Trevor (Eds.), Basic & clinical pharmacology. McGraw-Hill. Retrieved December 10, 2017, from http:\/\/0-accesspharmacy.mhmedical.com.library.acaweb.org\/content.aspx?bookid=1193&sectionid=69108439"},{"key":"14_CR45","doi-asserted-by":"crossref","unstructured":"Sirohi, S., Dighe, S. V., Madia, P. A., & Yoburn, B. C. (2009). The relative potency of inverse opioid agonists and a neutral opioid antagonist in precipitated withdrawal and antagonism of analgesia and toxicity. The Journal of Pharmacology and Experimental Therapeutics , 330(2), 513\u2013519.","DOI":"10.1124\/jpet.109.152678"},{"issue":"9","key":"14_CR38","doi-asserted-by":"publisher","first-page":"825","DOI":"10.2146\/ajhp070392","volume":"66","author":"J Stringer","year":"2009","unstructured":"Stringer, J., Welsh, C., & Tommasello, A. (2009). Methadone-associated QT interval prolongation and torsades de pointes. American Journal of Health-System Pharmacy, 66(9), 825\u2013833.","journal-title":"American Journal of Health-System Pharmacy"},{"key":"14_CR39","volume-title":"SAMHSA opioid overdose prevention toolkit. HHS Publication No. (SMA) 18\u20134742","author":"Substance Abuse and Mental Health Services Administration","year":"2018","unstructured":"Substance Abuse and Mental Health Services Administration. (2018). SAMHSA opioid overdose prevention toolkit. HHS Publication No. (SMA) 18\u20134742. Rockville, MD."},{"key":"14_CR40","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.drugalcdep.2009.10.011","volume":"108","author":"JM Trigo","year":"2010","unstructured":"Trigo, J. M., Martin-Garcia, E., Berrendero, F., Robledo, P., & Maldonado, R. (2010). The endogenous opioid system: A common substrate in drug addiction. Drug and Alcohol Dependence, 108, 183\u2013194.","journal-title":"Drug and Alcohol Dependence"},{"key":"14_CR43","doi-asserted-by":"publisher","unstructured":"Volkow, N. D., Wang, G. J., Fowler, J. S., & Tomasi, D. (2012). Addiction circuitry in the human brain. Annual Review of Pharmacology and Toxicology 52(1), 321\u2013336. https:\/\/doi.org\/10.1146\/pharmtox.2012.52.issue-110.1146\/annurev-pharmtox-010611-134625","DOI":"10.1146\/pharmtox.2012.52.issue-110.1146\/annurev-pharmtox-010611-134625"},{"issue":"2","key":"14_CR41","first-page":"341","volume":"51","author":"JM Van Ree","year":"1999","unstructured":"Van Ree, J. M., Gerrits, M. A. F. M., & Vanderschuren, L. J. M. J. (1999). Opioids, reward and addiction: An encounter of biology, psychology, and medicine. Pharmacological Review; The American Society for Pharmacology and Experimental Therapeutics, 51(2), 341\u2013396.","journal-title":"Pharmacological Review; The American Society for Pharmacology and Experimental Therapeutics"}],"container-title":["Advances in Neurobiology","Endogenous Opioids"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-3-031-45493-6_14","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T04:35:10Z","timestamp":1793853310000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/chapter\/10.1007\/978-3-031-45493-6_14"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024]]},"ISBN":["9783031454929","9783031454936"],"references-count":47,"URL":"https:\/\/doi.org\/10.1007\/978-3-031-45493-6_14","relation":{},"ISSN":["2190-5215","2190-5223"],"issn-type":[{"value":"2190-5215","type":"print"},{"value":"2190-5223","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024]]},"assertion":[{"value":"15 June 2024","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}